362 related articles for article (PubMed ID: 27457366)
1. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
7. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
Brunner J; Sitzmann FC
Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
[TBL] [Abstract][Full Text] [Related]
9. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B
Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
[TBL] [Abstract][Full Text] [Related]
11. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
12. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).
Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y
Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064
[TBL] [Abstract][Full Text] [Related]
14. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
van Rossum M; van Soesbergen R; de Kort S; ten Cate R; Zwinderman AH; de Jong B; Dijkmans B; van Venrooij WJ
J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
19. Limitations in the classification of childhood-onset rheumatoid arthritis.
Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
